You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
四環醫藥(00460.HK)奪CELLBOOSTER獨家代理權 另8款婦科敷料類產品獲頒醫療器械註冊證
阿思達克 03-07 09:34
四環醫藥(00460.HK)公布,其附屬渼顏空間近日與瑞士Suisselle就CELLBOOSTER系列產品達成獨家代理協議,獲得該產品在中國,香港、澳門及台灣的獨家代理權。 Suisselle專注於透明質酸和創新細胞領域的研發治療。CELLBOOSTER系列產品是新一代水光針產品,應用了Suisselle獨特的物理交聯的CHAC專利技術,成為第一個獲得歐盟CE認證的穩定複合物,標誌著該產品在歐洲經濟區已被評估為符合高度的安全、健康和環境保護要求,可實現在歐盟成員國範圍內的自由流通。 此外,公司宣布渼顏空間生物科技(吉林)所研發的共8款婦科敷料類產品,獲得中國國家藥監局頒發的醫療器械註冊證。 是次獲批的婦科敷料類產品包括醫用婦科抗菌凝膠敷料,醫用婦科護理凝膠,卡波姆陰道凝膠,卡波姆婦科凝膠,醫用陰道阻菌液體敷料,醫用婦科沖洗液體敷料,醫用陰道阻菌凝膠及醫用婦科引導填塞敷料。8款產品均為II類醫療器械,可通過在陰道壁形成一層保護性凝膠膜,從而阻止病原微生物定植,有促進陰道自淨及創面癒合的作用。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account